Drug interaction. 2. How drugs interactHARTSHORN, Edward A.The Annals of pharmacotherapy. 2006, Vol 40, Num 3, pp 542-549, issn 1060-0280, 8 p.Article

Drug safety, drug quality, drug analysisGÖRÖG, Sandor.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 2, pp 247-253, issn 0731-7085, 7 p.Conference Paper

The Food and Drug Administration's Drug Safety Oversight Board: An Evolving Paradigm for Clinical Input on Drug SafetyTopicsGRANDINETTI, C. A; OSBORNE, S. F.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 2, pp 269-274, issn 0009-9236, 6 p.Article

Mesoporous silica material TUD-1 as a drug delivery systemHEIKKILÄ, T; SALONEN, J; HIRVONEN, J et al.International journal of pharmaceutics. 2007, Vol 331, Num 1, pp 133-138, issn 0378-5173, 6 p.Article

Knowledge of food and drug administration reportable deviationsLAM, Rebecca; BRYANT, Barbara J.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 7, pp 1619-1623, issn 0041-1132, 5 p., 2Article

US food and drug administration pushed to changeMCCARTY, Michael.Lancet (British edition). 2006, Vol 367, Num 9523, issn 0140-6736, 1630,1643-1644 [3 p.]Article

La DroguePELICIER, Yves; THUILLIER, Guy.1992, 127 p., isbn 2-130-44843-7Book

SCALES AND BLINKERS, MOTES AND BEAMS: WHOSE VIEW IS OBSTRUCTED ON DRUG SCHEDULING?ROOM, Robin.Addiction (Abingdon. Print). 2011, Vol 106, Num 11, pp 1895-1896, issn 0965-2140, 2 p.Article

FDA Perspective on Companion Diagnostics: An Evolving Paradigm : PRECISION MEDICINEMANSFIELD, Elizabeth A.Clinical cancer research (Print). 2014, Vol 20, Num 6, pp 1453-1457, issn 1078-0432, 5 p.Article

Why the FDA can't protect the publicLENZER, Jeanne; BROWNLEE, Shannon.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7780, pp 966-968, issn 1759-2151, 3 p.Article

Razlike medu ovisnicima delinkventima s obzirom na direktnu i indirektnu involviranost u kriminalitet vezan uz drogu = Differences between the delinquent addicts in relation with direct and indirect involvement in the drugs related criminality = Différences entre les toxicomanes délinquants en relation avec une implication directe ou indirecte dans la criminalité liée à la drogueBUTORAC, Ksenija; TODOROVIC, Ljiljana Miksaj.Kriminologija & socijalna integracija. 2002, Vol 10, Num 1, pp 35-47, issn 1330-2604, 13 p.Article

Molybdenum hydroxylases as drug-metabolizing enzymesBEEDHAM, C; DAMANI, L. A.Drug metabolism reviews (Softcover ed.). 1985, Vol 16, Num 1-2, pp 119-156, issn 0360-2532Article

Role of the Food and drug Administration in the use of molecular techniques in immunohematologyKOCHMAN, Sheryl A.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 1S, issn 0041-1132, 3S-9S, SUPConference Paper

A food and drug administration primer : Drug evaluation in the United States, Canada, and the European UnionSIMON, Lee S.Arthritis care and research. 2006, Vol 55, Num 1, pp 4-8, issn 0893-7524, 5 p.Article

Regulating Off-Label Drug Use : Rethinking the Role of the FDASTAFFORD, Randall S.The New England journal of medicine. 2008, Vol 358, Num 14, pp 1427-1429, issn 0028-4793, 3 p.Article

Adverse drug events in children: The US food and drug administration perspective : Adverse drug events and adverse drug reactions in pediatrics patientsRODRIGUEZ, William; ROBERTS, Rosemary; MURPHY, Dianne et al.Current therapeutic research. 2001, Vol 62, Num 10, pp 711-723, issn 0011-393XConference Paper

Regulatory, design, and analysis aspects of complex stability studiesFAIRWEATHER, W. R; LIN, T.-Y. D; KELLY, R et al.Journal of pharmaceutical sciences. 1995, Vol 84, Num 11, pp 1322-1326, issn 0022-3549Article

Drug development and the FDA's critical path initiativeWOOSLEY, R. L; COSSMAN, J.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 1, pp 129-133, issn 0009-9236, 5 p.Article

Information deficits in the summary of product characteristics preclude an optimal management of drug interactions : a comparison with evidence from the literatureBERGK, Verena; HAEFELI, Walter E; GASSE, Christiane et al.European journal of clinical pharmacology. 2005, Vol 61, Num 5-6, pp 327-335, issn 0031-6970, 9 p.Article

Protein function classification via support vector machine approachCAI, C. Z; WANG, W. L; SUN, L. Z et al.Mathematical biosciences. 2003, Vol 185, Num 2, pp 111-122, issn 0025-5564, 12 p.Article

Liver cells and drugs, Rennes, July 7-10, 1987 = Cellules hépatiques et médicamentsGuillouzo, André.Colloques INSERM. 1988, issn 0768-3154, isbn 0-86196-128-5, XIX-494 p, isbn 0-86196-128-5Conference Proceedings

Detection of Multiple Disease Indicators by an Autonomous Biomolecular ComputerGIL, Binyamin; KAHAN-HANUM, Maya; SKIRTENKO, Natalia et al.Nano letters (Print). 2011, Vol 11, Num 7, pp 2989-2996, issn 1530-6984, 8 p.Article

Development of cardiovascular drugs: The U.S. regulatory milieu from the perspective of a participating nonregulatorBORER, Jeffrey S.Journal of the American College of Cardiology. 2004, Vol 44, Num 12, pp 2285-2292, issn 0735-1097, 8 p.Article

Meeting the challenge of FDA's CMC initiativesKARLTON, P.Pharmaceutical technology. 1996, Vol 20, Num 10, pp 90-100, issn 0147-8087, 7 p.Article

Drug FeverPATEL, Ruchi A; GALLAGHER, Jason C.Pharmacotherapy. 2010, Vol 30, Num 1, pp 57-69, issn 0277-0008, 13 p.Article